Latest Breaking News On - Dell faulkingham - Page 2 : comparemela.com

Akebia Therapeutics Reports Third Quarter 2021 Financial Results and Highlights Recent Company Milestones

/PRNewswire/ Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney.

United statesUnited kingdomDavida spellmanDell faulkinghamRon friesonMercedes carrascoJohnp butlerDrug administrationExchange commissionAkebia therapeutics incBellsouth corporationJapan ministry of healthEuropean medicines agencyOtsuka international agreementAmerican society of nephrology kidney weekAtlanta urban league

Akebia Therapeutics, inc (AKBA) Q2 2021 Earnings Call Transcript

Akebia Therapeutics, inc (AKBA) Q2 2021 Earnings Call Transcript
fool.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fool.com Daily Mail and Mail on Sunday newspapers.

United statesVifor pharmaPiper sandlerSteven burkeDavid spellmanRobert hazlettChris raymondBratzel piper sandlerDell faulkinghamKristen sheppardJohn butlerSteering committeeEuropean medicines agencyFresenius medical careAkebia therapeuticsAkebia therapeutics second quarter

Akebia Therapeutics, inc (AKBA) Q2 2021 Earnings Call Transcript

Akebia Therapeutics, inc (AKBA) Q2 2021 Earnings Call Transcript
msn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from msn.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomEd arceVifor pharmaDavid lebovitzNina cantor fitzgeraldSteven burkeRobert hazlettAlethia youngBratzel piper sandlerJones morgan stanleyDell faulkinghamJohn butlerDan clark mizuhoPiper sandlerDan clark